Veeva

Cloud-based Software for the Global Life Sciences Industry

Veeva is a leading global provider of industry-specific, cloud-based software solutions for the life sciences industry. Our solutions enable pharmaceutical and other life sciences companies to realize the benefits of modern cloud-based architectures and mobile applications for their most critical business functions, without compromising industry-specific functionality or regulatory compliance.

Latest News

November 4, 2020 Veeva to Release Fiscal 2021 Third Quarter Results on December 1, 2020
PLEASANTON, CA — Nov. 4, 2020 — Veeva Systems (NYSE: VEEV) will announce financial results for its third quarter which ended October 31, 2020 after market close on December 1, 2020.  Veeva will host a conference call and webcast that day at 1:30 p.m. PT (4:30 p.m. ET) to discuss its financial results. Event:              Veeva’s Fiscal 2021 Third Quarter Results Conference Call Date:                Tuesday, December 1, 2020 Time:               1:30 p.m. PT (4:30 p.m. ET) Online Registration: www.directeventreg.com Conference ID: 3283186 Webcast:         ir.veeva.com A webcast replay will be available on Veeva’s investor relations website following the call. Veeva Systems Inc. is a leader in cloud solutions—including data, software, and...
August 27, 2020 Veeva Announces Fiscal 2021 Second Quarter Results
Total Revenues of $353.7M, up 33% Year-over-year; Subscription Services Revenues of $283.5M, up 30% Year-over-year Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its fiscal second quarter ended July 31, 2020. “We are focused on helping the industry as the move to streamline drug development and enable digital engagement has gone from strategic imperative to operational necessity,” said CEO Peter Gassner. “Our team's dedication to customer success, bringing creative solutions, and delivering significant product innovations with speed, is more important than ever as life sciences steps up to meet the challenge of a lifetime.” Fiscal 2021 Second Quarter Results: Revenues : Total revenues for the second quarter were $353.7 million, up from $266.9 million one year ago, an increase of 33% year-over-year. Subscription services revenues for the second quarter were $283.5 million, up from $217.3...

Investor Contact

Rick Lund
Investor Relations Vice President
ir@veeva.com

Email Alerts

Email *
Mailing Lists *



 
Enter the code shown above.